TIDMMAV4 TIDMTTM
RNS Number : 5353W
Maven Income & Growth VCT 4 PLC
27 April 2016
Maven Income and Growth VCT 4 PLC
Result of Annual General Meeting
At the Annual General Meeting of the Company held at 10.30 am at
Fifth Floor, 1-2 Royal Exchange Buildings, London, EC3V 3LF on 27
April 2016, all of the Resolutions put to the Meeting were duly
passed.
At the record date for the Annual General Meeting, being 25
April 2016, the total number of voting rights in the Company stood
at 33,345,502 Ordinary Shares. In accordance with the provisions of
D.2.2 of the Combined Code on Corporate Governance, the Company
advises that for the Annual General Meeting, valid proxy
appointments were made in respect of 3,502,560 shares and that the
number of proxy votes lodged for each Resolution were as
follows:
Resolutions For Discretion Against Withheld Total
--- ---------------------------- ---------- ----------- -------- --------- ----------
To receive the Annual
Report and audited
1 Financial Statements. 3,365,091 116,840 20,629 0 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To approve the Directors'
2 Remuneration Report. 3,228,502 119,493 97,679 56,886 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To approve a final
3 dividend. 3,380,427 116,840 5,293 0 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To re-elect Mr Cormack
4 as a Director. 3,322,833 116,840 55,279 7,608 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To re-elect Mr Graham-Wood
5 as a Director. 3,322,986 116,840 55,126 7,608 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To re-elect Mr Scott
6 as a Director. 3,307,964 116,840 70,148 7,608 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To re-elect Mr Nixon
7 as a Director. 3,337,027 118,503 39,422 7,608 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To appoint Deloitte
8 LLP as Auditor. 3,336,536 122,530 34,682 8,812 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To authorise the
Directors to fix
the remuneration
9 of the Auditor. 3,367,361 122,530 7,644 5,025 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To authorise the
Directors to allot
10 new shares. 3,353,682 121,491 10,053 17,334 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To authorise disapplication
11 of pre-emption rights. 3,271,857 121,491 75,716 33,496 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To authorise the
Company to purchase
12 its own shares. 2,848,267 122,530 521,732 10,031 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
To allow a General
Meeting to be called
on not less than
13 14 days' notice. 3,216,309 122,530 141,434 22,287 3,502,560
--- ---------------------------- ---------- ----------- -------- --------- ----------
A vote withheld is not a vote in law and any such votes have not
been included in the votes for or against the respective
Resolutions. The voting figures will be available to view at:
www.mavencp.com/migvct4.
Passing of Resolutions under Special Business
Copies of Resolutions passed under Special Business have been
submitted to the National Storage Mechanism and will shortly be
available for inspection at: www.morningstar.co.uk/uk/NSM.
Issued on behalf of the Board
Maven Capital Partners UK LLP, Secretary
27 April 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGBBGDSLUDBGLR
(END) Dow Jones Newswires
April 27, 2016 07:58 ET (11:58 GMT)
Maven Income & Growth Vc... (LSE:MAV4)
Historical Stock Chart
From Apr 2024 to May 2024
Maven Income & Growth Vc... (LSE:MAV4)
Historical Stock Chart
From May 2023 to May 2024